Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Gene+ logo — Omics for better health

Gene+

Omics for better health

Founded 2015 China Beijing, China 92 employees Series B Biotechnology

General Information

Company Name Gene+
Founded Year 2015
Location China Beijing, China
Employees 92
Industries Biotechnology
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Gene+. To contact Gene+, visit en.geneplus.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Gene+

Founded in 2015, Gene+ is a genetic testing and precision oncology company dedicated to the development and commercialization of next-generation sequencing products and services. Gene+ offers a range of comprehensive genomic profiling assays to identify the genetic alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials using fully automatic bioinformatic analysis, interpretation and report generating system. With its CAP-accredited, EMQN-accredited and ISO-accredited clinical laboratories, Gene+ has been able to serve its customers with the highest standards and best quality, accumulating more than 400,000 samples tested. Using big data platform of cancer genomics, Gene+ has developed a deep cooperation and connection with its partners ranging from biotechs, biopharmas to research institutes, including MD Anderson Cancer, Duke University, BeiGene, and AstraZeneca etc, with more than 400 collaboration projects in scientific research and clinical application and more than 230 publications in Science, Nature Genetics, Nature Medicine, etc. For more information, please visit our website at en.geneplus.cn or contact us at [email protected].

Taxonomy: Genetic Research and Development, Next-Generation Sequencing, Precision Oncology, Molecular Diagnostics, Comprehensive Genomic Profiling, Molecular Testing, Cancer Genomics, Smart Laboratory, Bioinformatic Analysis, Immunotherapies, Clinical Trials, Tumor Gene Detection, Precision Medicine, Early Tumor Screening

No funding data available for Gene+ yet.

Gene+ Alternatives & Competitors

Gene+ vs
Strand Life Sciences
Strand Life Sciences India

Personalized Genomics For A Healthier Future

Private Equity
637 employees
Biotechnology, Health Care
Gene+ vs
Geneseeq Technology Inc.
Geneseeq Technology Inc. Canada

Cancer: a word, not a sentence!

Series D
32 employees
Biotechnology, Health Care
Compare Gene+ vs Geneseeq Technology Inc.
Gene+ vs
MEDGENOME
MEDGENOME India

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

Series D
1011 employees
Biotechnology, Health Care
Compare Gene+ vs MEDGENOME

FAQ About Gene+

Omics for better health
Gene+ was founded in 2015.
Gene+ is headquartered in Beijing, China.
Gene+ operates in Biotechnology. Its work centres on Genetic Research and Development, Next-Generation Sequencing, Precision Oncology and Molecular Diagnostics.
Gene+ has approximately 92 employees.
Top alternatives and competitors to Gene+ include Strand Life Sciences, Geneseeq Technology Inc., MEDGENOME, TwinStrand Biosciences, Yikon Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gene+ and Strand Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Gene+, https://bouncewatch.com/company/gene-1, updated 9 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes